Skip to content

INFINITY™ EVERLAST™ 33683308Recalls & reported problems

Wright Medical Technology, Inc. · Class 2 · Implant

All models of INFINITY EVERLAST (20)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00889797074520), received between Jul 11, 2025 and Nov 12, 2025 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Pain2
  • Swelling/ Edema1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 12, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    SUBJECT: 200-041. INFINITY¿ WITH ADAPTIS¿ TOTAL ANKLE REPLACEMENT FOLLOW-UP (ITAR2). (B)(6) 2024: PATIENT REPORTED PERSISTENT PAIN AND SWELLING. NO FURTHER INFORMAT. (B)(6) 2024: PATIENT REPORTED PAIN WAS WORSENING. AE UPGRADED TO SAE AND PATIENT HAD THE FOLLOWING PROCEDURES PERFORMED: TARSAL TUNNEL RELEASE; RIGHT TENOSYNOVECTOMY FLEXOR HALLUCIS LONGUS RIGHT; EXCISION MEDIAL TALUS AND CALCANEUS OSTEOPHYTE RIGHT; BONE GRAFT MEDIAL MALLEOLAR CYST AND DEBRIDEMENT, MEDIAL ANKLE JOINT. (B)(6) 2024: PATIENT IMPROVING POST-OP BUT STILL EXPERIENCING ONGOING PERSISTENT PAIN IN SUBTALAR JOINT. STEROID INJECTION ADMINISTERED. (B)(6) 2025: MOST RECENT UPDATE STATES PATIENT REPORTS NO CHANGE AND STILL HAVING PAIN IN ANKLE JOINT AREA. ANOTHER STEROID INJECTION WAS ADMINISTERED.

    Patient problems: Pain; Swelling/ Edema

    MAUDE report 23536049 ↗
  • InjuryJul 11, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE DIGITAL STRYKER PROPHECY TEAM RECEIVED A CT SCAN INDICATING THAT THE PATIENT MAY REQUIRE A REVISION SURGERY FOR REASONS THAT ARE NOT AVAILABLE AT THE TIME OF THIS REPORT.

    Patient problems: Pain

    MAUDE report 22479854 ↗

Other PROSTHESIS, ANKLE, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER devices

All PROSTHESIS, ANKLE, SEMI-CONSTRAINED, CEMENTED, METAL/POLYMER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page